Latest Breaking News On - David rapoport - Page 8 : comparemela.com

email article Sleep medicine specialists are worried about a draft technology assessment from the Agency for Healthcare Research and Quality (AHRQ) that casts doubt on the long-term clinical benefit for the gold standard treatment for sleep apnea. Reviewers found that studies of continuous positive airway pressure (CPAP) have consistently failed to show improvements in non-sleep-related outcomes linked to obstructive sleep apnea (OSA), such as stroke, heart attack, diabetes, and depression. The report online at the AHRQ website and open for public comment through April 23 concluded that the published evidence mostly does not support that CPAP prescription affects long-term, clinically important outcomes, and it highlighted research gaps and methodological weaknesses in the available studies, along with significant CPAP compliance issues, which have all contributed to the failure to show long-term benefits for the treatment.

New yorkUnited statesDavid rapoportSanjay patelElise berlinerAmerican academy of sleep medicinePractice centersIcahn school of medicine at mount sinaiUniversity of pittsburghAgency for healthcare researchHealthcare researchMedpage todayIcahn schoolMount sinaiApnea hypopnea indexAmerican academy